Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model.

[1]  R. Bronson,et al.  MyD 88 Intrinsically Regulates CD 4 T-Cell Responses , 2014 .

[2]  C. Schmaljohn,et al.  Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses. , 2011, Virus research.

[3]  Virgil L. Woods,et al.  Crystal structure of the Lassa virus nucleoprotein–RNA complex reveals a gating mechanism for RNA binding , 2011, Proceedings of the National Academy of Sciences.

[4]  C. García,et al.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever. , 2011, Antiviral research.

[5]  P. Cannon,et al.  Substitutions in the Glycoprotein (GP) of the Candid#1 Vaccine Strain of Junin Virus Increase Dependence on Human Transferrin Receptor 1 for Entry and Destabilize the Metastable Conformation of GP , 2011, Journal of Virology.

[6]  A. Takada,et al.  Novel Arenavirus, Zambia , 2011, Emerging infectious diseases.

[7]  Cristina Marino Buslje,et al.  Molecular Determinants of Arenavirus Z Protein Homo-Oligomerization and L Polymerase Binding , 2011, Journal of Virology.

[8]  Ravi V. Kolla,et al.  Human CD8+ and CD4+ T Cell Memory to Lymphocytic Choriomeningitis Virus Infection , 2011, Journal of Virology.

[9]  S. Ross,et al.  Junín Virus Infects Mouse Cells and Induces Innate Immune Responses , 2011, Journal of Virology.

[10]  D. A. Stein,et al.  Development of Peptide-Conjugated Morpholino Oligomers as Pan-Arenavirus Inhibitors , 2011, Antimicrobial Agents and Chemotherapy.

[11]  I. Lukashevich,et al.  Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs. , 2011, Vaccine.

[12]  S. Kunz,et al.  Pathogenesis of arenavirus hemorrhagic fevers , 2011, Expert review of anti-infective therapy.

[13]  E. Kurt-Jones,et al.  Induction and Inhibition of Type I Interferon Responses by Distinct Components of Lymphocytic Choriomeningitis Virus , 2010, Journal of Virology.

[14]  S. Günther,et al.  T Cell-Dependence of Lassa Fever Pathogenesis , 2010, PLoS pathogens.

[15]  W. Ian Lipkin,et al.  Nosocomial Outbreak of Novel Arenavirus Infection, Southern Africa , 2009, Emerging infectious diseases.

[16]  W. Ian Lipkin,et al.  Genetic Detection and Characterization of Lujo Virus, a New Hemorrhagic Fever–Associated Arenavirus from Southern Africa , 2009, PLoS pathogens.

[17]  N. Tordo,et al.  Early and Strong Immune Responses Are Associated with Control of Viral Replication and Recovery in Lassa Virus-Infected Cynomolgus Monkeys , 2009, Journal of Virology.

[18]  D. Rogers,et al.  Risk Maps of Lassa Fever in West Africa , 2009, PLoS neglected tropical diseases.

[19]  I. Lukashevich,et al.  Vaccines Against Lassa Fever , 2009 .

[20]  R. Bronson,et al.  MyD88 Intrinsically Regulates CD4 T-Cell Responses , 2008, Journal of Virology.

[21]  K. Mansfield,et al.  Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates. , 2008, Vaccine.

[22]  C. Roth,et al.  New opportunities for field research on the pathogenesis and treatment of Lassa fever. , 2008, Antiviral research.

[23]  Michael R Holbrook,et al.  Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. , 2008, Antiviral research.

[24]  D. Golenbock,et al.  Lymphocytic Choriomeningitis Virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses , 2008, Journal of Neuroimmunology.

[25]  S. Akira,et al.  Lymphocytoid Choriomeningitis Virus Activates Plasmacytoid Dendritic Cells and Induces a Cytotoxic T-Cell Response via MyD88 , 2007, Journal of Virology.

[26]  S. Tardif,et al.  Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target Tissues , 2007, Journal of Virology.

[27]  Barbara S. Stewart,et al.  Identification of Protective Lassa Virus Epitopes That Are Restricted by HLA-A2 , 2006, Journal of Virology.

[28]  R. Tesh,et al.  Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with Pirital virus (Arenaviridae): a rodent model of Lassa fever. , 2006, The American journal of tropical medicine and hygiene.

[29]  M. Wolfe,et al.  Historical Lassa Fever Reports and 30-year Clinical Update , 2006, Emerging infectious diseases.

[30]  I. Lukashevich,et al.  A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses , 2005, Journal of Virology.

[31]  K. Sundar,et al.  Lassa Fever Virus Peptides Predicted by Computational Analysis Induce Epitope-Specific Cytotoxic-T-Lymphocyte Responses in HLA-A2.1 Transgenic Mice , 2005, Clinical Diagnostic Laboratory Immunology.

[32]  D. Golenbock,et al.  MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection , 2005, European journal of immunology.

[33]  I. Lukashevich,et al.  LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration , 2004, Archives of Virology.

[34]  A. Hoerauf,et al.  Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. , 2004, Virology.

[35]  Debbie Baglole,et al.  Lassa fever: epidemiology, clinical features, and social consequences , 2003, BMJ : British Medical Journal.

[36]  E. Wherry,et al.  Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells1 , 2003, The Journal of Immunology.

[37]  Philip K. Russell,et al.  Hemorrhagic fever viruses as biological weapons: medical and public health management. , 2002, JAMA.

[38]  J. McCormick,et al.  Lassa fever. , 2002, Current topics in microbiology and immunology.

[39]  M. Oldstone.  Biology and pathogenesis of lymphocytic choriomeningitis virus infection. , 2002, Current topics in microbiology and immunology.

[40]  P. Jahrling,et al.  Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses , 2001, Journal of Virology.

[41]  I. Lukashevich,et al.  Lassa virus activity in Guinea: Distribution of human antiviral antibody defined using enzyme‐linked immunosorbent assay with recombinant antigen , 1993, Journal of medical virology.

[42]  G. Cole,et al.  Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus , 1993, Journal of virology.

[43]  I. Lukashevich.  Generation of reassortants between African arenaviruses. , 1992, Virology.

[44]  F. Byl,et al.  Audiometric Comparison of Lassa Fever Hearing Loss and Idiopathic Sudden Hearing Loss: Evidence for Viral Cause , 1992, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[45]  J. McCormick,et al.  Acute sensorineural deafness in Lassa fever. , 1990, JAMA.

[46]  Lukashevich Is,et al.  [Lassa and Mozambique viruses: cross protection in experiments on mice and action of immunosuppressants on experimental infections]. , 1989 .

[47]  P. Jahrling,et al.  Experimental studies of arenaviral hemorrhagic fevers. , 1987, Current topics in microbiology and immunology.

[48]  J. McCormick,et al.  Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.

[49]  K. McIntyre,et al.  Exquisite specificity of adoptive immunization in arenavirus-infected mice. , 1985, Antiviral research.

[50]  Lukashevich Is.  Lassa virus lethality for inbred mice. , 1985 .

[51]  I. Lukashevich.  Lassa virus lethality for inbred mice. , 1985, Annales de la Societe belge de medecine tropicale.